INGN Q2 2020 Earnings — Inogen, Inc. Revenue & Financial Results | Market Cap Arena

INGNInogen, Inc.

$172M

Q2 2020 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$72M-29.1% YoY

Gross Profit

$33M45.7% margin

Operating Income

-$2M-3.3% margin

Net Income

$3M3.6% margin

EPS (Diluted)

$0.12

QoQ Revenue Growth

-19.0%

Cash Flow

Operating Cash Flow

$14M

Free Cash Flow

$10M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$458M

Total Liabilities

$107M

Stockholders' Equity

$351M

Cash & Equivalents

$214M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$72M	$101M	-29.1%
Gross Profit	$33M	$50M	-34.8%
Operating Income	-$2M	$12M	-119.4%
Net Income	$3M	$10M	-74.6%

Geographic Segments

UNITED STATES

$58M81%

Non Us

$14M19%